"All kinds of enhancements" have crept into claims from providers, Ronanki said, and health plans have responded. But his ...

In an interview, James D. Chambers, Ph.D., from Tufts Medical Center, talks about the factors that are impacting the ...

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

These tools, available through the myCigna member portal, are designed to make navigating health insurance more ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young HIV patients achieve medication adherence and undetectable viral loads.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

The company's CEO points to using a subscription-based model, being a platform that allows for technology integration and scale and transparency.

According to a new study in Haemophilia, up to 60% of patients with severe HA have no known family history, making early ...

Findings mark the first time a neoadjuvant immunotherapy regimen has demonstrated a significant survival benefit in a ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...